BelkinaACNikolajczykBSDenisGV. 2013. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol. 190(7):3670–3678.
2.
FengQZhangZSheaMJCreightonCJCoarfaCHilsenbeckSGLanzRHeBWangLFuX. 2014. An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res. 24(7):809–819.
3.
GhayorCCorreroRMLangeKKarfeld-SulzerLSGrätzKWWeberFE. 2011. Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone. J Biol Chem. 286(27):24458–24466.
4.
KhanYMKirkhamPBarnesPJAdcockIM. 2014. Brd4 is essential for IL-1beta-induced inflammation in human airway epithelial cells. PLoS One. 9(4):e95051.
5.
MengSZhangLTangYTuQZhengLYuLMurrayDChengJKimSHZhouX. 2014. BET inhibitor JQ1 blocks inflammation and bone destruction. J Dent Res. 93(7):657–662.
6.
MiguelBSGhayorCEhrbarMJungREZwahlenRAHortschanskyPSchmoekelHGWeberFE. 2009. N-methyl pyrrolidone as a potent bone morphogenetic protein enhancer for bone tissue regeneration. Tissue Eng Part A. 15(10):2955–2963.
7.
ShorttJHsuAKMartinBPDoggettKMatthewsGMDoyleMAEllulJJockelTEAndrewsDMHoggSJ. 2014. The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound. Cell Rep. 7(4):1009–1019.
8.
TangYGholaminSSchubertSWillardsonMILeeABandopadhayayPBergtholdGMasoudSNguyenBVueN.2014. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nat Med. 20(7):732–740.
9.
VenkataramanSAlimovaIBalakrishnanIHarrisPBirksDKGriesingerAAmaniVCristianoBRemkeMTaylorMD. 2014. Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 5(9):2355–2371.
